Putting Patients First Blog

SEPTEMBER 3, 2024

Overall, while the NHC appreciates CMS’ intent to streamline the data submission process and make it more accessible, we encourage ongoing dialogue and adjustments to ensure that the process remains patient-centered, efficient, and capable of capturing the full spectrum of information necessary to inform meaningful drug price negotiations.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). We commend CMS for its commitment to improving these sessions and provide the following detailed recommendations.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Proxsys Rx

APRIL 1, 2025

Regardless of your answer, theres no question the 340B Drug Pricing Program remains a critical resource for eligible healthcare providers, enabling them to stretch scarce federal resources to provide essential services to underserved communities.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Drug Pricing 52

pharmaphorum

DECEMBER 24, 2020

Now, after a year that feels like it had many more than the usual 12 months, ‘digital’ has most certainly come of age across all aspects of our lives, including communication , commerce, working life and, yes, health. So, what were the standout changes for digital health, and digital pharma for that matter, in this most unusual of years?

Drug Pricing 126

Drug Pricing Communication 126

Big Molecule Watch

JANUARY 10, 2025

The updated guidance includes information on the general requirements for the content of FDA-regulated promotional communications about reference or biosimilar products and provides some examples to illustrate the FDAs current recommendations for addressing reference, biosimilar, and interchangeable biosimilar products in product promotion.

Biosimilars 45

Biosimilars Drug Pricing Labelling Communication 45

Proxsys Rx

OCTOBER 6, 2022

That’s why helping health systems minimize data mismatches at the source is so critical to maximizing 340B savings 340B drug pricing program savings for a covered entity — and why meeting that challenge is a core component of our 340B software and service package. There are many places where communication failures can and do occur.

Hospitals 52

Hospitals Drug Pricing Communication Pharmaceutical Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 14, 2023

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

Drug Development 98

Drug Development Drug Pricing Communication 98

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. It is too early to say because we have not seen the whole package of measures yet.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

Pulses

JANUARY 9, 2024

This topic could be informative in how we approach curricular design, student success, communication strategies, and college/school work and learning environments overall.

Drug Pricing 64

Drug Pricing Communication 64

Pulses

JANUARY 9, 2024

This topic could be informative in how we approach curricular design, student success, communication strategies, and college/school work and learning environments overall.

Drug Pricing 52

Drug Pricing Communication 52

pharmaphorum

FEBRUARY 18, 2021

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. Do not try and adapt your strategy to be a generic strategy – although price is important and difficult to compete against, don’t fight it.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

pharmacy mentor

JANUARY 15, 2023

Foster open communication and transparency Encourage sharing ideas, concerns, and feedback openly and honestly throughout your team. We understand that life in Community Pharmacy is usually high-speed, and can be very stressful. People follow leaders for their passion and because they align with their vision.

Community Pharmacies 52

Community Pharmacies Pharmacy Technician Drug Pricing Communication 52

The Nontraditional Pharmacist

NOVEMBER 20, 2019

Another area is a medical communication and scientific communications, which also includes publication planning. And once a communications plan in terms of what should be communicated and then what we call the scientific platform when it gets developed for a product or a device, etc.

Communication 52

Communication Drug Pricing 52

Putting Patients First Blog

APRIL 14, 2023

10: External Data Submission Timing The NHC understands the tight timeline for the drug selection and price negotiation processes. Created by and for patient organizations over 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

Putting Patients First Blog

JANUARY 27, 2025

This includes clear communication about how AI tools are used in clinical and administrative Transparency fosters trust and empowers patients and providers to actively participate in care decisions. Issue Brief: Improving Prescription Drug Price and Cost Transparency. 2024.30.2.206. 38 American Medical Association.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharmacy Is Right For Me

SEPTEMBER 21, 2022

This scholarship will provide me with the means to continue my research regarding health literacy for underserved communities. I am an intern for a community pharmacy where I see many examples of where communication can be improved between patients and staff. I hope to bring this research with me in my future career endeavors.

Community Pharmacies 130

Community Pharmacies Drug Pricing Communication 130

Pharmaceutical Technology

JANUARY 5, 2023

The survey results also indicated that drug pricing and reimbursement constraints will be the second biggest concern, hampering the industry’s growth, as indicated by 30% of the surveyed respondents. To adapt is the only way to thrive. The pharmaceutical sector will need to find new ways to offset regulatory and inflationary pressures.

Drug Pricing 69

Drug Pricing Vaccines Labelling Communication 69

Pharmaceutical Technology

JUNE 2, 2023

In a bit to challenge the market dominance of AbbVie’s Humira (adalimumab), the online pharmacy Cost Plus Drugs, owned by billionaire Mark Cuban has announced a plan to market Coherus Biosciences’ biosimilar Yusimry (adalimumab-aqvh), Cost Plus Drugs will be offering Yusimry at $569 per unit, excluding shipping and dispensing charges.

Biosimilars 52

Biosimilars Online Pharmacies Drug Pricing Communication 52

Pharmaceutical Technology

JANUARY 16, 2023

The topic of inflation overlaps with drug pricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drug prices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Pharmaceutical Technology

DECEMBER 9, 2022

There are also strict price controls, which in some cases can limit profitability for manufacturers. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

JANUARY 16, 2023

The topic of inflation overlaps with drug pricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drug prices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Documentation 97

Documentation Hospitals Dosage Drug Pricing 97

Pharmaceutical Technology

FEBRUARY 7, 2023

An example is NICE’s Quality Adjusted Life Year score, used to price drugs in the UK. Some nations such as France base their decisions on the drug’s medical benefit and clinical added value versus existing therapies. Please check your email to download the Case Study.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Inpatient Drug Pricing Packaging 52

Pharma Marketing Network

APRIL 1, 2025

Elevated prices can lead to decreased affordability and reduced patient adherence, prompting marketers to adjust their branding and value propositions strategically. Pharma marketers must ensure transparent communication with healthcare providers, patients, and insurers about pricing changes influenced by pharma tariffs.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

Pharmaceutical Technology

MAY 24, 2023

The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced steps to push down prescription drug prices under Medicaid as part of a new proposal. Please check your email to download the Report.

Drug Pricing 52

Drug Pricing Vaccines Labelling Communication 52

Drug Patent Watch

DECEMBER 18, 2024

It’s all about clear communication and finding common ground with the examiner.” ” Maximizing Patent Term Given the long development timelines for drugs, maximizing your patent term is crucial. Balancing Profit and Public Health Pharmaceutical companies face increasing scrutiny over drug pricing and access.

Drug Development 98

Drug Development Compounding Dosage Pharmaceutical Companies 98